Ironwood begins the rolling NDA filing for apraglutide to treat short bowel syndrome patients dependent on parenteral support.

Plastic waste in Nigeria presents a dual challenge: cleaning up environmental pollution, and tapping into its economic ...

The following is a summary of “Neurofilament heavy chain in secondary progressive multiple sclerosis,” published in the January 2025 issue of Neurology by Angelis et al. Biomarkers are essential for ...

A study of NCAA Division I football players revealed persistent atrophy in the quadriceps and gastrocnemius muscles 2 years ...

During a machine learning and data science hackathon, teams provided coach Russell Payne new insights driven by AI.

People with shorter protective caps at the end of their chromosomes (called telomeres) may be more likely to develop ...

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on study results, an analyst ...

Design Therapeutics' GeneTAC platform is revolutionizing genetic disease treatment with small molecules and promising results ...

The layoffs will allow Ironwood to dedicate more resources to pushing its lead molecule apraglutide through a Phase III trial ...

Several upcoming reports, detailing the city’s ability to distribute water for residential, business and firefighting uses, ...

Jupiter is actively exploring additional strategic partnerships to expand JOTROL’s application across other neuroinflammatory and metabolic disorders, including Alzheimer’s disease and longevity ...

An exploration well will be drilled in Durdevac, Croatia as part of a wider geothermal exploration campaign by local oil and ...